Mirtazapine Tablet, Film Coated
Product Images NDC 72162-2562

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 72162-2562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622562)

This text provides information about a medication containing 7.5 mg Mirtazapine in tablet form. It includes details such as the usual dosage, storing conditions, prescribing information, and the need to dispense a medication guide to each patient. The medication is to be dispensed in a tight, light-resistant container as per USP guidelines. Bryant Ranch Prepack, Inc., and Aurobindo Pharma Limited are mentioned as manufacturers. The medication should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Additionally, it emphasizes keeping the drug out of reach of children.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.